Oncology Practice2 = 5 for additional AI therapy for postmenopausal HR+ breast cancerDecember 8, 2017Breast CancerPatient & Survivor Care
Oncology PracticeShaping practice: Z1071 continues to redefine axillary managementDecember 8, 2017Breast Cancer
Oncology PracticeVIDEO: CDK4/6, ET, LHRH combo improves PFS in premenopausal breast cancerDecember 8, 2017Breast Cancer
Oncology PracticeAcupuncture significantly reduces AI-associated arthralgiasDecember 8, 2017Breast CancerPatient & Survivor Care
Oncology PracticeVIDEO: 5 years of additional AI no better than 2 in HR+ breast cancerDecember 8, 2017Breast CancerPatient & Survivor Care
Oncology PracticeNo evidence for perioperative AI benefit in early ER/PR+ breast cancerDecember 8, 2017Breast Cancer
Oncology PracticeDose intensification gets more mileage out of adjuvant chemoDecember 8, 2017Breast Cancer
Oncology PracticeRibociclib plus standard of care improves PFS in premenopausal HR+/HER2-negative breast cancerDecember 7, 2017Breast Cancer
Oncology PracticeVIDEO: Dr. Matteo Lambertini answers questions on temporary ovarian suppressionDecember 7, 2017Breast CancerPatient & Survivor Care
Oncology PracticeNovel ADC shows promise in metastatic triple-negative breast cancerDecember 7, 2017Breast Cancer
Oncology PracticeVIDEO: Good responses with antibody-drug conjugate in third-line metastatic TNBC therapyDecember 7, 2017Breast Cancer
Oncology PracticeVIDEO: Dr. Sherene Loi discusses PANACEA trial and implications for pembrolizumab useDecember 7, 2017Breast CancerImmuno-oncology
Oncology PracticeVIDEO: Meta-analysis lead author Dr. Richard Gray on dose intensity benefitDecember 7, 2017Breast Cancer